E. Corbett, C. Watt, N. Walker, D. Maher, B. Williams et al., The Growing Burden of Tuberculosis, Archives of Internal Medicine, vol.163, issue.9, pp.1009-1030, 2003.
DOI : 10.1001/archinte.163.9.1009

O. Enfants, Available from: http://www.unaids.org/fr/resources/documentsAvailablefrom:http://www.unaids.org/sites/default/files/sub_landing/files/UNAID S_Global_Report_2013_en_4.pdf 5. WHO | Antiretroviral therapy for HIV infection in infants and children, WHO, 2010.

S. Swaminathan, Tuberculosis in HIV-infected children, Paediatric Respiratory Reviews, vol.5, issue.3, pp.225-255, 2004.
DOI : 10.1016/j.prrv.2004.04.006

P. Jeena, P. Pillay, T. Pillay, and H. Coovadia, Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.6, issue.8, pp.672-680, 2002.

J. Kiwanuka, S. Graham, J. Coulter, J. Gondwe, N. Chilewani et al., Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi, Annals of Tropical Paediatrics, vol.2, issue.1, pp.5-14, 2001.
DOI : 10.1093/tropej/44.5.266

H. Schaaf, S. Krook, D. Hollemans, R. Warren, P. Donald et al., Recurrent Culture-Confirmed Tuberculosis in Human Immunodeficiency Virus-Infected Children, The Pediatric Infectious Disease Journal, vol.24, issue.8, pp.685-91, 2005.
DOI : 10.1097/01.inf.0000172933.22481.36

M. Espinal, A. Reingold, G. Pérez, E. Camilo, S. Soto et al., Human Immunodeficiency Virus Infection in Children with Tuberculosis in Santo Domingo, Dominican Republic: Prevalence, Clinical Findings, and Response to Antituberculosis Treatment, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.13, issue.2, pp.155-164, 1996.
DOI : 10.1097/00042560-199610010-00006

H. Schaaf, B. Marais, A. Whitelaw, A. Hesseling, B. Eley et al., Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases, BMC Infectious Diseases, vol.25, issue.Suppl 1, p.140, 2007.
DOI : 10.1097/01.inf.0000183751.75880.f8

S. Madhi, K. Petersen, A. Madhi, M. Khoosal, and K. Klugman, Increased Disease Burden and Antibiotic Resistance of Bacteria Causing Severe Community-Acquired Lower Respiratory Tract Infections in Human Immunodeficiency Virus Type 1-Infected Children, Clinical Infectious Diseases, vol.31, issue.1, pp.170-176, 2000.
DOI : 10.1086/313925

O. Daniel, O. Ogunfowora, and O. Oladapo, HIV sero-prevalence among children diagnosed withTB in Nigeria, Tropical Doctor, vol.37, issue.4, pp.268-277, 2007.
DOI : 10.1258/004947507782333080

H. Coovadia, P. Jeena, and D. Wilkinson, Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.2, issue.10, pp.844-51, 1998.

Y. Mukadi, S. Wiktor, I. Coulibaly, D. Coulibaly, A. Mbengue et al., Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire, AIDS Lond Engl Jul, vol.1511, issue.9, pp.1151-1159, 1997.

I. Palme, B. Gudetta, J. Bruchfeld, L. Muhe, and J. Giesecke, Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis, The Pediatric Infectious Disease Journal, vol.21, issue.11, pp.1053-61, 2002.
DOI : 10.1097/00006454-200211000-00016

N. Elenga, K. Kouakoussui, D. Bonard, P. Fassinou, M. Anaky et al., Diagnosed Tuberculosis During the Follow-up of a Cohort of Human Immunodeficiency Virus-Infected Children in Abidjan, C??te d??Ivoire, The Pediatric Infectious Disease Journal, vol.24, issue.12, pp.1077-82, 2005.
DOI : 10.1097/01.inf.0000190008.91534.b7

B. Marais, H. Rabie, and M. Cotton, TB and HIV in children ??? advances in prevention and management, Paediatric Respiratory Reviews, vol.12, issue.1, pp.39-45, 2011.
DOI : 10.1016/j.prrv.2010.09.002

N. Martinson, H. Moultrie, R. Van-niekerk, G. Barry, A. Coovadia et al., HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.13, issue.7, pp.862-869, 2009.

E. Walters, M. Cotton, H. Rabie, H. Schaaf, L. Walters et al., Clinical presentation and outcome of Tuberculosis in Human Immunodeficiency Virus infected children on anti-retroviral therapy, BMC Pediatrics, vol.42, issue.suppl 1, p.1, 2008.
DOI : 10.1086/499953

A. Kouakoussui, P. Fassinou, M. Anaky, N. Elenga, R. Laguide et al., Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast, Paediatric Respiratory Reviews, vol.5, issue.4, pp.311-316, 2004.
DOI : 10.1016/j.prrv.2004.07.008

A. Edmonds, J. Lusiama, S. Napravnik, F. Kitetele, A. Van-rie et al., Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children, International Journal of Epidemiology, vol.38, issue.6, pp.1612-1633, 2009.
DOI : 10.1093/ije/dyp208

Z. Toossi, Virological and Immunological Impact of Tuberculosis on Human Immunodeficiency Virus Type 1 Disease, The Journal of Infectious Diseases, vol.188, issue.8, pp.1146-55, 2003.
DOI : 10.1086/378676

F. Blanc, T. Sok, D. Laureillard, L. Borand, C. Rekacewicz et al., Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis, New England Journal of Medicine, vol.365, issue.16, pp.1471-81, 2011.
DOI : 10.1056/NEJMoa1013911

L. Porte, C. Colbers, E. Bertz, R. Voncken, D. Wikstrom et al., Pharmacokinetics of Adjusted-Dose Lopinavir-Ritonavir Combined with Rifampin in Healthy Volunteers, Antimicrobial Agents and Chemotherapy, vol.48, issue.5, pp.1553-60, 2004.
DOI : 10.1128/AAC.48.5.1553-1560.2004

G. Meintjes and G. Maartens, Dosing of raltegravir when given with rifampicin, The Lancet Infectious Diseases, vol.14, issue.6, pp.442-445
DOI : 10.1016/S1473-3099(14)70739-X

M. Boyd, X. Zhang, A. Dorr, K. Ruxrungtham, S. Kolis et al., Lack of Enzyme-Inducing Effect of Rifampicin on the Pharmacokinetics of Enfuvirtide, The Journal of Clinical Pharmacology, vol.24, issue.2, 2003.
DOI : 10.1177/0091270003259220

Y. Ren, J. Nuttall, B. Eley, T. Meyers, P. Smith et al., Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.50, issue.5, pp.439-482, 1999.
DOI : 10.1097/QAI.0b013e31819c33a3

J. Oudijk, H. Mcilleron, V. Mulenga, C. Chintu, C. Merry et al., Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment, AIDS, vol.26, issue.12, pp.1523-1531, 2012.
DOI : 10.1097/QAD.0b013e3283550e20

H. Moultrie, H. Mcilleron, S. Sawry, T. Kellermann, L. Wiesner et al., Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir, Journal of Antimicrobial Chemotherapy, vol.70, issue.2, pp.543-552, 2015.
DOI : 10.1093/jac/dku382

P. Thomas, K. Bornschlegel, T. Singh, E. Abrams, J. Cervia et al., Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City. The New York City Pediatric Spectrum of HIV Disease Consortium, Pediatr Infect Dis J, vol.19, issue.8, pp.700-706, 2000.

J. Cohen, E. Whittaker, S. Walters, H. Lyall, G. Tudor-williams et al., Presentation, diagnosis and management of tuberculosis in HIV-infected children in the UK, HIV Medicine, vol.20, issue.5, pp.277-84, 2008.
DOI : 10.1016/S0140-6736(04)17592-2

S. Blanche, C. Dollfus, F. A. Rouzioux, C. Mandelbrot, L. Tubiana et al., Le sida pédiatrique, 30 ans plus tard. Arch Pédiatrie, pp.890-896, 2013.

J. Jensen, A. Álvaro-meca, D. Micheloud, A. Díaz, and S. Resino, Reduction in Mycobacterial Disease Among HIV-infected Children in the Highly Active Antiretroviral Therapy Era (1997???2008), The Pediatric Infectious Disease Journal, vol.31, issue.3, pp.278-83, 1997.
DOI : 10.1097/INF.0b013e318239e268

A. Okechukwu and O. Okechukwu, Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria, Nigerian Journal of Clinical Practice, vol.14, issue.2, 2011.
DOI : 10.4103/1119-3077.84018

C. Delacourt, Particularités de la tuberculose chez l'enfant. Rev Mal Respir, pp.529-570, 2011.

B. Decludt, Infection et maladie tuberculeuse de l'enfant en Ile de France en 1997

S. Chan, J. Birnbaum, M. Rao, and P. Steiner, Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome, The Pediatric Infectious Disease Journal, vol.15, issue.5, pp.443-450, 1996.
DOI : 10.1097/00006454-199605000-00012

A. Hesseling, A. Westra, H. Werschkull, P. Donald, N. Beyers et al., Outcome of HIV infected children with culture confirmed tuberculosis, Archives of Disease in Childhood, vol.90, issue.11, pp.1171-1175, 2005.
DOI : 10.1136/adc.2004.070466

P. Sonnenberg, J. Glynn, K. Fielding, J. Murray, P. Godfrey-faussett et al., How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold Miners, The Journal of Infectious Diseases, vol.191, issue.2, pp.150-158, 2005.
DOI : 10.1086/426827

L. Abuogi, C. Mwachari, H. Leslie, S. Shade, J. Otieno et al., Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya, The International Journal of Tuberculosis and Lung Disease, vol.17, issue.10, pp.1291-1298, 2013.
DOI : 10.5588/ijtld.12.0740

Z. Dangor, A. Izu, K. Hillier, F. Solomon, N. Beylis et al., Impact of the Antiretroviral Treatment Program on the Burden of Hospitalization for Culture-confirmed Tuberculosis in South African Children, The Pediatric Infectious Disease Journal, vol.32, issue.9, pp.972-979, 2013.
DOI : 10.1097/INF.0b013e31828d9aa4

T. Pensi, A. Hemal, and T. Banerjee, Simultaneous HAART improves survival in children coinfected with HIV and TB, Tropical Medicine & International Health, vol.7, issue.1, 2011.
DOI : 10.1111/j.1365-3156.2011.02884.x

N. Markowitz, N. Hansen, T. Wilcosky, P. Hopewell, J. Glassroth et al., Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons, Annals of Internal Medicine, vol.119, issue.3, pp.185-93, 1993.
DOI : 10.7326/0003-4819-119-3-199308010-00002

M. Santin, L. Muñoz, and D. Rigau, Interferon-?? Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-Analysis, PLoS ONE, vol.48, issue.6, p.32482, 2012.
DOI : 10.1371/journal.pone.0032482.t008

S. Liebeschuetz, S. Bamber, K. Ewer, J. Deeks, A. Pathan et al., Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study, The Lancet, vol.364, issue.9452, pp.2196-203, 2004.
DOI : 10.1016/S0140-6736(04)17592-2

M. Davies, T. Connell, C. Johannisen, K. Wood, S. Pienaar et al., Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay, AIDS, vol.23, issue.8, pp.961-970, 2009.
DOI : 10.1097/QAD.0b013e32832956ad

D. Abadco and P. Steiner, Gastric lavage is better than bronchoalveolar lavage for isolation of Mycobacterium tuberculosis in childhood pulmonary tuberculosis, The Pediatric Infectious Disease Journal, vol.11, issue.9, 1992.
DOI : 10.1097/00006454-199209000-00013

M. Singh, N. Moosa, L. Kumar, and M. Sharma, Role of gastric lavage and broncho-alveolar lavage in the bacteriological diagnosis of childhood pulmonary tuberculosis, Indian Pediatr, 2000.

N. Somu, S. Swaminathan, C. Paramasivan, D. Vijayasekaran, A. Chandrabhooshanam et al., Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children, Tubercle and Lung Disease, vol.76, issue.4, pp.295-304, 1995.
DOI : 10.1016/S0962-8479(05)80027-9

E. Venturini, A. Turkova, E. Chiappini, L. Galli, M. De-martino et al., Tuberculosis and HIV co-infection in children, BMC Infectious Diseases, vol.14, issue.Suppl 1, p.5, 2014.
DOI : 10.1186/1471-2334-14-S1-S5

J. Smith, B. Mueller, R. Nussenblatt, and S. Whitcup, Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for mycobacterium avium complex bacteremia, American Journal of Ophthalmology, vol.127, issue.2, pp.164-173, 1999.
DOI : 10.1016/S0002-9394(98)00310-9

M. Krauss, D. Harris, T. Abreu, F. Ferreira, N. Ruz et al., Tuberculosis in HIVinfected infants, children, and adolescents in Latin America, Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2015 Feb, vol.19, issue.1, pp.23-32

A. Habtewold, E. Makonnen, W. Amogne, G. Yimer, G. Aderaye et al., Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study, Pharmacogenomics, vol.16, issue.10, pp.1-17, 2015.
DOI : 10.2217/pgs.15.35

J. Mukonzo, S. Nanzigu, P. Waako, J. Ogwal-okeng, L. Gustafson et al., genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure, Pharmacogenomics, vol.15, issue.11, pp.1423-1458, 2014.
DOI : 10.2217/pgs.14.73

Y. Ren, J. Nuttall, C. Egbers, B. Eley, T. Meyers et al., Effect of Rifampicin on Lopinavir Pharmacokinetics in HIV-Infected Children With Tuberculosis, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.47, issue.5, pp.566-575, 1999.
DOI : 10.1097/QAI.0b013e3181642257

P. Gurumurthy, G. Ramachandran, H. Kumar, A. Rajasekaran, S. Padmapriyadarsini et al., Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.280-283, 2004.

J. Sahai, K. Gallicano, L. Swick, S. Tailor, G. Garber et al., Reduced Plasma Concentrations of Antituberculosis Drugs in Patients with HIV Infection, Annals of Internal Medicine, vol.127, issue.4, pp.289-93, 1997.
DOI : 10.7326/0003-4819-127-4-199708150-00006

G. Ramachandran, A. Kumar, P. Bhavani, T. Kannan, S. Kumar et al., Pharmacokinetics of First-Line Antituberculosis Drugs in HIV-Infected Children with Tuberculosis Treated with Intermittent Regimens in India, Antimicrobial Agents and Chemotherapy, vol.59, issue.2, 2015.
DOI : 10.1128/AAC.04338-14

S. Graham, D. Bell, S. Nyirongo, R. Hartkoorn, S. Ward et al., Low Levels of Pyrazinamide and Ethambutol in Children with Tuberculosis and Impact of Age, Nutritional Status, and Human Immunodeficiency Virus Infection, Antimicrobial Agents and Chemotherapy, vol.50, issue.2, 2006.
DOI : 10.1128/AAC.50.2.407-413.2006

H. Khachi, O. Connell, R. Ladenheim, D. Orkin, and C. , Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection, Journal of Antimicrobial Chemotherapy, vol.64, issue.4, pp.871-874, 2009.
DOI : 10.1093/jac/dkp263

M. Weiner, D. Benator, C. Peloquin, W. Burman, A. Vernon et al., Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.1343-1352, 2005.

O. Hsu, C. Hill, M. Kim, B. Tan, O. Brien et al., Decreased plasma efavirenz concentrations in a patient receiving rifabutin. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, pp.1611-1615, 2010.

N. Bhatt, C. Barau, A. Amin, E. Baudin, M. B. Silva et al., Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment, Antimicrobial Agents and Chemotherapy, vol.58, issue.6, pp.3182-90
DOI : 10.1128/AAC.02379-13

S. Thee, J. Seddon, P. Donald, H. Seifart, C. Werely et al., Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization Recommendations, Antimicrobial Agents and Chemotherapy, vol.55, issue.12, pp.5560-5567, 2011.
DOI : 10.1128/AAC.05429-11

A. Pozniak, K. Coyne, R. Miller, M. Lipman, A. Freedman et al., British HIV Association guidelines for the treatment of TB/HIV coinfection 2011, HIV Medicine, vol.51, issue.(Suppl 4), 2011.
DOI : 10.1111/j.1468-1293.2011.00954.x